Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy

Journal of Cardiovascular Electrophysiology

Volumn 25, Issue 5, 2014, Pages 507-513

  Bose, Abhishek ^a   Kandala, Jagdesh ^a   Upadhyay, Gaurav A ^a   Riedl, Lindsay ^a   Ahmado, Imad ^a   Padmanabhan, Ram ^a   Gewirtz, Henry ^a   Mulligan, Lawrence J ^b   Singh, Jagmeet P ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Medtronic Minneapolis   (United States)

Author keywords

cardiac resynchronization therapy; heart failure; implantable cardioverter defibrillator; ischemia; myocardial scar

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIURETIC AGENT;

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CARDIAC RESYNCHRONIZATION THERAPY; DEATH; DEVICE THERAPY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; INCIDENCE; ISCHEMIC CARDIOMYOPATHY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; MYOCARDIAL PERFUSION IMAGING; PHLEBOGRAPHY; PRIORITY JOURNAL; RECIPIENT; RETROSPECTIVE STUDY; SCAR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX RADIOGRAPHY; VERY ELDERLY; ANGIOCARDIOGRAPHY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOMYOPATHIES; CHI SQUARE DISTRIBUTION; CICATRIX; COMPLICATION; DISEASE FREE SURVIVAL; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TIME; TISSUE SURVIVAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; CARDIOMYOPATHIES; CHI-SQUARE DISTRIBUTION; CICATRIX; CORONARY ANGIOGRAPHY; DISEASE-FREE SURVIVAL; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL PERFUSION IMAGING; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TISSUE SURVIVAL; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84899660090     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12348     Document Type: Article

References (27)

1. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J,: MIRACLE study group. Multicenter insync randomized clinical evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845-1853.
2. Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P, Huth C, Schöndube F, Wolfhard U, Böcker D, Krahnefeld O, Kirkels H,: Pacing therapies in congestive heart failure (PATH-CHF) study group. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002; 39: 2026-2033.
3. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood GA, Santini M, Bailleul C, Daubert JC,: Multisite Stimulation in cardiomyopathies (MUSTIC) study investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001; 344: 873-880.
4. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM,: Comparison of medical therapy, pacing, and defibrillation in heart failure (COMPANION) investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-2150.
5. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L,: Cardiac resynchronization-heart failure (CARE-HF) study investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. New Engl J Med 2005; 352: 1539-1549.
6. Abraham WT, Hayes DL,: Cardiac resynchronization therapy for heart failure. Circulation 2003; 108: 2596-2603.
7. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K,: Multicenter insync icdrandomized clinical evaluation (MIRACLE ICD) trial investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD trial. JAMA-J Am Med Assoc 2003; 289: 2685-2694.
8. Kandala J, Altman RK, Park MY, Singh JP,: Clinical, laboratory, and pacing predictors of CRT response. J Cardiovasc Transl Res 2012; 5: 196-212.
9. Bax JJ, Bleeker GB, Marwick TH, Molhoek SG, Boersma E, Steendijk P, van der Wall EE, Schalij MJ,: Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 2004; 44: 1834-1840.
10. Singh JP, Klein HU, Huang DT, Reek S, Kuniss M, Quesada A, Barsheshet A, Cannom D, Goldenberg I, McNitt S, Daubert JP, Zareba W, Moss AJ,: Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial. Circulation 2011; 123: 1159-1166.
11. Ypenburg C, Schalij MJ, Bleeker GB, Steendijk P, Boersma E, Dibbets-Schneider P, Stokkel MP, van der Wall EE, Bax JJ,: Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. Eur Heart J 2007; 28: 33-41.
12. Ypenburg C, van Bommel RJ, Delgado V, Mollema SA, Bleeker GB, Boersma E, Schalij MJ, Bax JJ,: Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy. J Am Coll Cardiol 2008; 52: 1402-1409.
13. Adelstein EC, Tanaka H, Soman P, Miske G, Haberman SC, Saba SF, Gorcsan J III,: Impact of scar burden by single-photon emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy. Eur Heart J 2011; 32: 93-103.
14. Birnie D, DeKemp RA, Ruddy TD, Tang AS, Guo A, Williams K, Wassenar R, Lalonde M, Beanlands RS,: Effect of lateral wall scar on reverse remodeling with cardiac resynchronization therapy. Heart Rhythm 2009; 6: 1721-1726.
15. Xu YZ, Cha YM, Feng D, Powell BD, Wiste HJ, Hua W, Chareonthaitawee P,: Impact of myocardial scarring on outcomes of cardiac resynchronization therapy: Extent or location ? J Nucl Med 2012; 53: 47-54.
16. Altman RK, Parks KA, Schlett CL, Orencole M, Park MY, Truong QA, Deeprasertkul P, Moore SA, Barrett CD, Lewis GD, Das S, Upadhyay GA, Heist EK, Picard MH, Singh JP,: Multidisciplinary care of patients receiving cardiac resynchronization therapy is associated with improved clinical outcomes. Eur Heart J 2012; 33: 2181-2188.
17. Hansen CL, Goldstein RA, Akinboboye OO, Berman DS, Botvinick EH, Churchwell KB, Cooke CD, Corbett JR, Cullom SJ, Dahlberg ST, Druz RS, Ficaro EP, Galt JR, Garg RK, Germano G, Heller GV, Henzlova MJ, Hyun MC, Johnson LL, Mann A, McCallister BD Jr, Quaife RA, Ruddy TD, Sundaram SN, Taillefer R, Ward RP, Mahmarian JJ,: Myocardial perfusion and function: Single photon emission computed tomography. J Nucl Cardiol 2007; 14: e39-e60.
18. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS,: Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002; 105: 539-542.
19. Singh JP, Houser S, Heist EK, Ruskin JN,: The coronary venous anatomy: A segmental approach to aid cardiac resynchronization therapy. J Am Coll Cardiol 2005; 46: 68-74.
20. Merchant FM, Heist EK, McCarty D, Kumar P, Das S, Blendea D, Ellinor PT, Mela T, Picard MH, Ruskin JN, Singh JP,: Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomes. Heart Rhythm 2010; 7: 639-644.
21. Kandala J, Upadhyay GA, Altman RK, Bose A, Heist EK, Mela T, Singh JP,: Electrical delay in apically positioned left ventricular leads and clinical outcome after cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2013; 24: 182-187.
22. Adelstein EC, Saba S,: Scar burden by myocardial perfusion imaging predicts echocardiographic response to cardiac resynchronization therapy in ischemic cardiomyopathy. Am Heart J 2007; 153: 105-112.
23. Becker M, Zwicker C, Kaminski M, Napp A, Altiok E, Ocklenburg C, Friedman Z, Adam D, Schauerte P, Marx N, Hoffmann R,: Dependency of cardiac resynchronization therapy on myocardial viability at the LV lead position. JACC Cardiovasc Imaging 2011; 4: 366-374.
24. Riedlbauchova L, Brunken R, Jaber WA, Popová L, Patel D, Lánská V, Civello K, Cummings J, Burkhardt JD, Saliba W, Martin D, Schweikert R, Wilkoff BL, Grimm R, Natale A,: The impact of myocardial viability on the clinical outcome of cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2009; 20: 50-57.
25. Bleeker GB, Schalij MJ, Van Der Wall EE, Bax JJ,: Postero-lateral scar tissue resulting in non-response to cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2006; 17: 899-901.
26. Udelson JE, Coleman PS, Metherall J, Pandian NG, Gomez AR, Griffith JL, Shea NL, Oates E, Konstam MA,: Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Circulation 1994; 89: 2552-2561.
27. Dakik HA, Howell JF, Lawrie GM, Espada R, Weilbaecher DG, He ZX, Mahmarian JJ, Verani MS,: Assessment of myocardial viability with 99mTc-sestamibi tomography before coronary bypass graft surgery: Correlation with histopathology and postoperative improvement in cardiac function. Circulation 1997; 96: 2892-2898.